Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.
Neurology. 1998 Jul;51(1):289-92. doi: 10.1212/wnl.51.1.289.
Neurology. 1998.
PMID: 9674825
Clinical Trial.
Clinical safety of serial monthly administrations of gadopentetate dimeglumine in patients with multiple sclerosis: implications for natural history and early-phase treatment trials.
Tresley RM, Stone LA, Fields N, Maloni H, McFarland H, Frank JA.
Tresley RM, et al.
Neurology. 1997 Apr;48(4):832-5. doi: 10.1212/wnl.48.4.832.
Neurology. 1997.
PMID: 9109864
Item in Clipboard
ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions.
Calabresi PA, Fields NS, Farnon EC, Frank JA, Bash CN, Kawanashi T, Maloni H, Jacobson S, McFarland HF.
Calabresi PA, et al. Among authors: fields ns.
J Neuroimmunol. 1998 May 15;85(2):212-9. doi: 10.1016/s0165-5728(98)00008-3.
J Neuroimmunol. 1998.
PMID: 9630170
Item in Clipboard
Cite
Cite